Rockwell Medical Inc - Asset Resilience Ratio
Rockwell Medical Inc (RMTI) has an Asset Resilience Ratio of 17.56% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Rockwell Medical Inc debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Rockwell Medical Inc's Asset Resilience Ratio has changed over time. See Rockwell Medical Inc net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Rockwell Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Rockwell Medical Inc (RMTI) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $10.10 Million | 17.56% |
| Total Liquid Assets | $10.10 Million | 17.56% |
Asset Resilience Insights
- Good Liquidity Position: Rockwell Medical Inc maintains a healthy 17.56% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Rockwell Medical Inc Industry Peers by Asset Resilience Ratio
Compare Rockwell Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Tasly Pharmaceutical Group Co Ltd
SHG:600535 |
Drug Manufacturers - Specialty & Generic | 9.09% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.02% |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
Annual Asset Resilience Ratio for Rockwell Medical Inc (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Rockwell Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 10.03% | $5.94 Million | $59.21 Million | +6.29pp |
| 2023-12-31 | 3.74% | $1.95 Million | $52.17 Million | -20.68pp |
| 2022-12-31 | 24.42% | $11.39 Million | $46.63 Million | +5.57pp |
| 2021-12-31 | 18.85% | $9.16 Million | $48.57 Million | +6.00pp |
| 2020-12-31 | 12.86% | $10.00 Million | $77.75 Million | -19.30pp |
| 2019-12-31 | 32.15% | $14.25 Million | $44.32 Million | +11.57pp |
| 2018-12-31 | 20.58% | $10.82 Million | $52.56 Million | -21.35pp |
| 2017-12-31 | 41.93% | $24.65 Million | $58.78 Million | -7.08pp |
| 2016-12-31 | 49.02% | $40.76 Million | $83.15 Million | +4.06pp |
| 2015-12-31 | 44.96% | $39.48 Million | $87.82 Million | +24.62pp |
| 2014-12-31 | 20.33% | $19.93 Million | $98.00 Million | -12.76pp |
| 2013-12-31 | 33.10% | $12.03 Million | $36.36 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $17.03 Million | -- |
| 2011-12-31 | 36.98% | $11.81 Million | $31.94 Million | +4.68pp |
| 2010-12-31 | 32.29% | $11.94 Million | $36.97 Million | +32.18pp |
| 2004-12-31 | 0.12% | $9.00K | $7.70 Million | -0.01pp |
| 2003-12-31 | 0.13% | $9.00K | $7.04 Million | -0.09pp |
| 2002-12-31 | 0.22% | $14.00K | $6.45 Million | -4.62pp |
| 2001-12-31 | 4.84% | $293.00K | $6.06 Million | +1.13pp |
| 2000-12-31 | 3.70% | $150.00K | $4.05 Million | -- |
About Rockwell Medical Inc
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterily… Read more